Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Verbist

Showing results (471-480 of 588) with videos related to

Pageof 59
Sort By:
Nature Immunology|March 3, 2026
Exclusion of Notch from the contact site during efferocytosis restricts anticancer immunityZhenrui Li, Beisi Xu, Piyush Sharma, et al.
Bioorganic & Medicinal Chemistry Letters|April 9, 2008
5-Sulfonyl-benzimidazoles as selective CB2 agonistsBie M P Verbist, Michel A J De Cleyn, Michel Surkyn, et al.
JAMA|November 25, 2004
Association between antibiotic sales and public campaigns for their appropriate useIsabelle Bauraind, José-Maria Lopez-Lozano, Arielle Beyaert, et al.
Journal of Natural Products|October 1, 1994
Bistramides A, B, C, D, and K: a new class of bioactive cyclic polyethers from Lissoclinum bistratumJ F Biard, C Roussakis, J M Kornprobst, et al.
The Journal of Laryngology and Otology|July 25, 2022
Long-term functional outcomes in tumour stage T<sub>2</sub> glottic carcinoma after radiotherapyM Hendriksma, B J Heijnen, B M Verbist, et al.
Journal of Medicinal Chemistry|April 1, 1991
New derivatives of kanamycin B obtained by modifications and substitutions in position 6". 1. Synthesis and microbiological evaluationA Van Schepdael, J Delcourt, M Mulier, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|July 19, 2025
Safety and Efficacy of Treatment With the Luminor DCB and iVolution Stent in TASC C and D Femoropopliteal Atherosclerotic Disease: 12 and 24-Month Outcome of the T.I.N.T.I.N. Physician-Initiated TrialKoen Deloose, Laura Drudi, Jürgen Verbist, et al.
European Radiology|December 2, 2025
A deep learning model to reduce agent dose for contrast-enhanced MRI of the cerebellopontine angle cisternYunjie Chen, Rianne A Weber, Olaf M Neve, et al.
Journal of Microbiological Methods|January 5, 2002
Combined use of LC/MS and a biological test for rapid identification of marine mycotoxins produced by Trichoderma koningiiAnne Landreau, Yves François Pouchus, Claire Sallenave-Namont, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2011
Androgen receptor-positive salivary duct carcinoma: a disease entity with promising new treatment optionsHeidy C J Jaspers, Berit M Verbist, Rafke Schoffelen, et al.
Pageof 59

Showing results (471-480 of 588) with videos related to

Sort By:
Pageof 59
Nature Immunology|March 3, 2026
Exclusion of Notch from the contact site during efferocytosis restricts anticancer immunityZhenrui Li, Beisi Xu, Piyush Sharma, et al.
Bioorganic & Medicinal Chemistry Letters|April 9, 2008
5-Sulfonyl-benzimidazoles as selective CB2 agonistsBie M P Verbist, Michel A J De Cleyn, Michel Surkyn, et al.
JAMA|November 25, 2004
Association between antibiotic sales and public campaigns for their appropriate useIsabelle Bauraind, José-Maria Lopez-Lozano, Arielle Beyaert, et al.
Journal of Natural Products|October 1, 1994
Bistramides A, B, C, D, and K: a new class of bioactive cyclic polyethers from Lissoclinum bistratumJ F Biard, C Roussakis, J M Kornprobst, et al.
The Journal of Laryngology and Otology|July 25, 2022
Long-term functional outcomes in tumour stage T<sub>2</sub> glottic carcinoma after radiotherapyM Hendriksma, B J Heijnen, B M Verbist, et al.
Journal of Medicinal Chemistry|April 1, 1991
New derivatives of kanamycin B obtained by modifications and substitutions in position 6". 1. Synthesis and microbiological evaluationA Van Schepdael, J Delcourt, M Mulier, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|July 19, 2025
Safety and Efficacy of Treatment With the Luminor DCB and iVolution Stent in TASC C and D Femoropopliteal Atherosclerotic Disease: 12 and 24-Month Outcome of the T.I.N.T.I.N. Physician-Initiated TrialKoen Deloose, Laura Drudi, Jürgen Verbist, et al.
European Radiology|December 2, 2025
A deep learning model to reduce agent dose for contrast-enhanced MRI of the cerebellopontine angle cisternYunjie Chen, Rianne A Weber, Olaf M Neve, et al.
Journal of Microbiological Methods|January 5, 2002
Combined use of LC/MS and a biological test for rapid identification of marine mycotoxins produced by Trichoderma koningiiAnne Landreau, Yves François Pouchus, Claire Sallenave-Namont, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2011
Androgen receptor-positive salivary duct carcinoma: a disease entity with promising new treatment optionsHeidy C J Jaspers, Berit M Verbist, Rafke Schoffelen, et al.
Pageof 59